FDA NDC Directory · JSON-LD · Markdown
NDC 55910-046 · HUMAN OTC DRUG · CAPSULE, LIQUID FILLED
| Labeler / Manufacturer | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA207753 |
| Dosage form / route | CAPSULE, LIQUID FILLED · ORAL |
| Active ingredients | IBUPROFEN (200 mg/1) |
| Marketing started | 20200730 |
| Marketing ended | 20270201 |
| Package count | 5 |
Source: openFDA. Public-domain (CC0).